Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accurately, actin, adequacy, affixed, alter, Angiomax, antiplatelet, API, auction, audience, aztreonam, Barry, bleeding, Blue, Brazzell, Bush, caliber, campaign, cataract, cautionary, cautioned, cellular, certainty, cGMP, CIC, CMS, commonly, complaint, concomitant, consecutive, content, correspondingly, COSO, Court, covenant, Cowen, cytoskeleton, daily, detect, detection, dinucleotide, disclaim, disposition, District, diversion, divert, DTC, Dutch, Ecabet, EITF, ElestatTM, endothelial, energy, entirety, escalation, expressly, Frameworkissued, Giorgino, glaucoma, goal, harmful, healing, highest, hydrochloride, IMS, inappropriately, incidence, inflammatory, inInternal, intravenously, intrinsic, involuntarily, ISTA, kent, Keratectomy, Kiah, Kim, leave, legend, licensor, lump, macula, magnified, Medicaid, MedPointe, methodology, mgs, Mirco, mirroring, Morgan, municipal, narrower, olopatadine, Ontario, Oversight, parallel, passed, Pea, pertain, Pharma, Photorefractive, pilot, plaque, postoperative, predominantly, principle, proceed, proceeding, proof, punctal, purported, reconsidering, reform, regular, reliability, remedy, reset, resigned, resolution, retrospective, rimexolone, rupture, Senju, SG, shelf, Shield, slower, speak, spirometric, Stanley, suitable, Susan, swelling, Tan, thereunder, thrombin, title, tobramycin, transformed, travel, Treadway, unconsolidated, undue, unproven, unqualified, unspecified, unvested, vendor, Verispan, viability, vigorously, virtue, WARF, week, weekly, Wisconsin, worth, wound
Removed:
addressing, advancing, anniversary, approach, attached, attempting, auditing, Award, beneficially, biology, BioResearch, bottle, Boucher, brand, bridge, burning, California, Cardiff, Cardinal, characterized, check, Circuit, closely, cold, Columbia, Comdisco, commencing, conflict, conversion, coordinated, creating, deduction, delinquent, demonstrating, derive, Dr, economic, enterprise, entitle, evaporation, expert, facilitating, film, fixed, Francisco, frequency, front, geographical, Harden, historically, improper, improve, improved, influencing, influx, ingredient, input, Jackson, Kenan, Kendall, leader, left, lubricate, mark, matching, mentioned, Michael, mixture, moderate, month, nasal, negotiate, newly, nonmucosal, painful, palliative, par, percent, permanent, pharmacologist, pharmacology, preference, prime, problem, produced, Professor, promoted, pump, quoted, ratio, recipient, requiring, restore, retirement, royalty, RPE, salt, San, School, sensory, separately, showed, Society, spent, sputum, strong, substitute, substitution, terminating, tissue, trailing, transferred, untreated, upper, utility, venture, Vice, water, Woodstock, Yamasa, young
Filing tables
Filing exhibits
- 10-K Annual report
- 10.40 Amended and Restated Director Compensation Policy
- 10.41 Agreement Between Inspire and Barry G. Pea
- 10.42 Employee Confidentiality, Invention Assignment and Non-compete Agreement
- 10.43 Transistion Agreement
- 10.44 Exclusive License Agreement
- 10.56 Form of Inspire Pharmaceuticals Employee Stock Option Agreement
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)/15D-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)/15D-14(A)
- 32.1 Certification of CEO Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 Certification of CFO Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Related press release
ISPH similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333-114517) and Form S-8 (File No. 333-56360) of Inspire Pharmaceuticals, Inc. of our report dated March 11, 2005 relating to the financial statements, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting which is included in this Annual Report on Form 10-K.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
March 11, 2004